Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

DIPROCEL OINTMENT 0.05% [SIN03842P]

Active ingredients: DIPROCEL OINTMENT 0.05%

View product's general information
Last updated 24 April 2026

Product Info

DIPROCEL OINTMENT 0.05%

[SIN03842P]

Product information

Active Ingredient and Strength

BETAMETHASONE DIPROPIONATE EQV BETAMETHASONE - 0.5 MG/G

Dosage Form

OINTMENT

Manufacturer and Country

PT ORGANON PHARMA INDONESIA TBK - INDONESIA REP OF

Registration Number

SIN03842P

Licence Holder

ORGANON SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

D07AC01

Prescription-only Medicines with Exemptions for Supply without Prescription

As a topical preparation (as valerate or dipropionate salt) as a single agent not exceeding 0.1%

  • Indications: Symptomatic relief of inflammatory skin or scalp disorders such as dermatitis and eczema.

  • Maximum Daily Dose: Apply to the affected areas twice daily

  • Maximum Supply: 15g for cream/ointment/gel

  • 30ml for topical solution

  • Minimum age: 18 years

Indication

INDICATIONS AND USAGE: DIPROCEL Ointment is indicated for the relief of the inflammatory manifestations of resistant or severe psoriasis and corticosteroid-responsive dermatoses.

Dosing

DOSAGE AND ADMINISTRATION: A thin film of DIPROCEL Ointment should be applied to cover completely the affected area once daily, in the morning.

DIPROCEL Ointment may also be applied twice daily, in the morning and at night, at the physician’s discretion.

As with all highly active topical corticosteroid preparations, treatment should be discontinued when the dermatologic disorder is controlled. According to clinical response, duration of therapy may vary from a few days to a longer period of time. However, treatment should not be continued for more than four weeks without patient re-evaluation.

Contraindications

CONTRAINDICATIONS: DIPROCEL Ointment is contraindicated in those patients with a history of sensitivity reactions to betamethasone dipropionate, other corticosteroids or to any of the components of DIPROCEL Ointment.